QQ客服 官方微博 反馈留言

	Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7
	Kong, YanGuo; Barisone, Gustavo A.; Abuhay, Mastewal; O'Donnell, Robert T.; Buksh, Zaneb; Yousefian, Faraz; Tuscano, Joseph M.
	2014
卷号	38期号:11页码:1320-1326
关键词	AR42 HB22.7 Lymphoma Anti-cancer drugs CD22 NHL
ISSN号	0145-2126
DOI	10.1016/j.leukres.2014.08.014
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6685236
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Kong, YanGuo,Barisone, Gustavo A.,Abuhay, Mastewal,et al. Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7[J],2014,38(11):1320-1326.
APA	Kong, YanGuo.,Barisone, Gustavo A..,Abuhay, Mastewal.,O'Donnell, Robert T..,Buksh, Zaneb.,...&Tuscano, Joseph M..(2014).Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7.,38(11),1320-1326.
MLA	Kong, YanGuo,et al."Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7".38.11(2014):1320-1326.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。